Amylin’s Byetta LAR Lowers Glucose, Weight

Diabetes market is big enough for liraglutide and other drugs, Amylin CEO tells “The Pink Sheet” DAILY.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet